Design Considerations for Two-Stage Enrichment Clinical Trials
- 27 November 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 79 (3) , 2565-2576
Abstract
When there is a predictive biomarker, enrichment can focus the clinical trial on a benefiting subpopulation. We describe a two-stage enrichment design, in which the first stage is designed to efficiently estimate a threshold and the second stage is a “phase III-like” trial on the enriched population. The goal of this paper is to explore design issues: sample size in Stages 1 and 2, and re-estimation of the Stage 2 sample size following Stage 1. By treating these as separate trials, we can gain insight into how the predictive nature of the biomarker specifically impacts the sample size. We also show that failure to adequately estimate the threshold can have disastrous consequences in the second stage. While any bivariate model could be used, we assume a continuous outcome and continuous biomarker, described by a bivariate normal model. The correlation coefficient between the outcome and biomarker is the key to understanding the behavior of the design, both for predictive and prognostic biomarkers. Through a series of simulations we illustrate the impact of model misspecification, consequences of poor threshold estimation, and requisite sample sizes that depend on the predictive nature of the biomarker. Such insight should be helpful in understanding and designing enrichment trials.Keywords
This publication has 12 references indexed in Scilit:
- Designing precision medicine trials to yield a greater population impactBiometrics, 2019
- Randomization: The forgotten component of the randomized clinical trialStatistics in Medicine, 2018
- Inference for multimarker adaptive enrichment trialsStatistics in Medicine, 2017
- An adaptive design for updating the threshold value of a continuous biomarkerStatistics in Medicine, 2016
- Adaptive Designs for Confirmatory Clinical Trials with Subgroup SelectionJournal of Biopharmaceutical Statistics, 2014
- Adaptive enrichment designs for clinical trialsBiostatistics, 2013
- Unplanned adaptations before breaking the blindStatistics in Medicine, 2012
- The Case for Personalized MedicineJournal of Diabetes Science and Technology, 2009
- Adaptive patient enrichment designs in therapeutic trialsBiometrical Journal, 2009
- The multivariate skew-normal distributionBiometrika, 1996